CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer

Author(s):: Zoni, E.; Chen, L.; Karkampouna, S.; Granchi, Z.; Verhoef, E.I.; La Manna, F.; Kelber, J.; Pelger, R.C.M.; Henry, M.D.; Snaar-Jagalska, B.E.; Leenders, G.J.L.H. van; Beimers, L.; Kloen, P.; Gray, P.C.; Pluijm, G. van der; Kruithof-de Julio, M.

Published: 2017
Publication type: Article / Letter to editor

Date issued: 2017
Language: English
Is part of: Oncogene (2017), Vol. 36, p. 4739-4749
hdl: 1887/57644
doi: 10.1038/onc.2017.87
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562855/pdf/onc201787a.pdf